These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The G263X MYBPC3 mutation is a common and low-penetrant mutation for hypertrophic cardiomyopathy in the region of Asturias (Northern Spain). Reguero JR; Gómez J; Martín M; Flórez JP; Morís C; Iglesias S; Alonso B; Alvarez V; Coto E Int J Cardiol; 2013 Oct; 168(4):4555-6. PubMed ID: 23870641 [No Abstract] [Full Text] [Related]
57. The enigmatic diversity of hypertrophic cardiomyopathy. Brito D Rev Port Cardiol; 2005 Dec; 24(12):1479-84. PubMed ID: 16566406 [No Abstract] [Full Text] [Related]
58. A predominant cardiac phenotype of Anderson-Fabry disease in presence of a MYBPC3 gene mutation and a LAMA4 gene mutation. Laenens D; Koopman P; Cools T Acta Cardiol; 2019 Feb; 74(1):84-85. PubMed ID: 29415625 [No Abstract] [Full Text] [Related]
59. Hypertrophic cardiomyopathy--beyond the sarcomere. St John Sutton M; Epstein JA N Engl J Med; 1998 Apr; 338(18):1303-4. PubMed ID: 9562586 [No Abstract] [Full Text] [Related]
60. Cardiac myosin-binding protein C in the heart. Carrier L Arch Mal Coeur Vaiss; 2007 Mar; 100(3):238-43. PubMed ID: 17536430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]